[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transfection Reagents and Equipment Market, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

May 2018 | 306 pages | ID: GA3B9E2B1C3EN
Data Bridge Market Research

US$ 4,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global transfection reagents and equipment market is expected to reach USD 649.20 million by 2025 and is projected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.

The key market players for global transfection reagents and equipment market are listed below:
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • MAXCYTE, INC.
  • LONZA
  • Polyplus-transfection SA
  • Mirus Bio LLC
  • Sigma-Aldrich, Inc.
  • SignaGen Laboratories
  • Genlantis, Inc.
The market is further segmented into:
  • Product
  • Method
  • Application
  • End users
The global transfection reagents and equipment market is segmented based on products into two segments; reagents and equipment. In 2018, reagents segment is estimated to rule with 79.1% shares rising at a specified CAGR. However, equipment is growing at the highest CAGR in the forecast period of 2018 to 2025.

The global transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method. In 2018, physical segment is valued to rule with the highest shares and rising at the highest CAGR. Physical segment is dominating the market as it was the initial choice for the transfection and highly efficient. Physical method is further sub segmented into electroporation, nucleofection and others. Other physical method is further divided into genegun, magnetofection, sonoporation and optoinjection. Biochemical method is segmented into lipofection, calcium phosphate, deae-dextran and dendrimers. Viral method is divided into 4 sub segments including adenoviruses, retroviruses, adeno associated viruses and others.

Based on application, the global transfection reagents and equipment market is segmented into biomedical research, protein production and therapeutic delivery. In 2018, protein production segment is projected to rule with highest market shares, rising at the highest CAGR. Protein production is dominating the market as protein is essential requirement for food, healthcare and cosmetics so the protein production is the major application of transfection procedure. Biomedical application is further sub segmented into gene expression studies, cancer research and transgenic models.

The global transfection reagents and equipment market is segmented based on end user into two notable segments; academics & research institutes and pharmaceutical & biotechnology companies. In 2018, academics & research institutes segment is likely to rule with the highest market shares and rising at the highest CAGR. The academics & research institutes are dominating the market as more research is being carried out in research organizations. And research organizations later on licensed out to industries for further development of products.

Based on geography, the market is segmented into 5 geographical regions:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa
Covered in this report

The report covers the present scenario and the growth prospects of the global transfection reagents and equipment market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION

1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Global Transfection Reagents And Equipment Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered

2 MARKET SEGMENTATION

2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 The Category Vs Time Grid
2.8 Secondary Sources
2.9 Assumptions

3 MARKET OVERVIEW

3.1 Drivers
  3.1.1 Rising Research Activities In Cell Science And Increase In Demand Of Chimeric Genes
  3.1.2 Increasing R&D Spending And Research Activities By Pharmaceutical And Biotech Companies
  3.1.3 Technological Advancements In Transfection Technology
  3.1.4 Alliances Between The Leading Research Institutes To Trigger Drug Discovery
  3.1.5 Rising Prevalence Of Chronic Indications
3.2 Restraints
  3.2.1 Selective Effectiveness Of Transfection Reagents Or Instruments
  3.2.2 High Cost Of Transfection Reagents And Equipment
  3.2.3 Home Brew Reagents Limits The Sale Of Commercial Kits
3.3 Opportunities
  3.3.1 Efficient Nuclear Delivery Method
  3.3.2 Emerging Markets
3.4 Challenges
  3.4.1 Slow Rate Of Transfection In Hard Cells
  3.4.2 Cytotoxicity Effects Due To Transfection Reagents

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY PRODUCT

6.1 Overview
6.2 Reagent
6.3 Equipment

7 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHOD

7.1 Overview
7.2 Physical Method
  7.2.1 Electroporation
  7.2.2 Nucleofection
  7.2.3 Others
    7.2.3.1 Genegun
    7.2.3.2 Magnetofection
    7.2.3.3 Sonoporation
    7.2.3.4 Optoinjection
7.3 Biochemical Methods
  7.3.1 Lipofection
  7.3.2 Calcium Phosphate
  7.3.3 Deae-Dextran
  7.3.4 Dendrimers
7.4 Viral Method
  7.4.1 Retroviruses
  7.4.2 Adenoviruses
  7.4.3 Adenoassociated Viruses
  7.4.4 Others

8 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY APPLICATION

8.1 Overview
8.2 Protein Production
8.3 Biomedical Research
  8.3.1 Gene Expression Studies
  8.3.2 Cancer Research
  8.3.3 Transgenic Models
8.4 Therapeutic Delivery

9 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY END USER

9.1 Overview
9.2 Academics & Research Institutes
9.3 Pharmaceutical & Biotechnology Companies

10 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT, BY GEOGRAPHY

10.1 Overview
10.2 North America
  10.2.1 U.S.
  10.2.2 Canada
  10.2.3 Mexico
10.3 Europe
  10.3.1 Germany
  10.3.2 U.K.
  10.3.3 France
  10.3.4 Italy
  10.3.5 Spain
  10.3.6 Switzerland
  10.3.7 Netherlands
  10.3.8 Belgium
  10.3.9 Russia
  10.3.10 Turkey
  10.3.11 Rest Of Europe
10.4 Asia-Pacific
  10.4.1 China
  10.4.2 Japan
  10.4.3 South Korea
  10.4.4 India
  10.4.5 Singapore
  10.4.6 Australia
  10.4.7 Thailand
  10.4.8 Malaysia
  10.4.9 Indonesia
  10.4.10 Philippines
  10.4.11 Rest Of Asia-Pacific
10.5 South America
  10.5.1 Brazil
  10.5.2 Rest Of South America
10.6 Middle East And Africa
  10.6.1 South Africa
  10.6.2 Rest Of Middle East And Africa

11 GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE

11.1 Company Share Analysis: Global
11.2 Company Share Analysis: North America
11.3 Company Share Analysis: Europe
11.4 Company Share Analysis: Asia-Pacific

12 COMPANY PROFILE

12.1 Thermo Fisher Scientific Inc.
  12.1.1 Company Overview
  12.1.2 Revenue Analysis
  12.1.3 Company Share Analysis
  12.1.4 Product Portfolio
  12.1.5 Recent Developments
12.2 Sigma-Aldrich, Inc. (Subsidiary Of Merck Kgaa)
  12.2.1 Company Overview
  12.2.2 Geographical Presence
  12.2.3 Company Share Analysis
  12.2.4 Product Portfolio
  12.2.5 Recent Developments
12.3 Promega Corporation
  12.3.1 Company Overview
  12.3.2 Geographical Presence
  12.3.3 Company Share Analysis
  12.3.4 Product Portfolio
  12.3.5 Recent Developments
12.4 Qiagen
  12.4.1 Company Overview
  12.4.2 Revenue Analysis
  12.4.3 Company Share Analysis
  12.4.4 Product Portfolio
  12.4.5 Recent Developments
12.5 Bio-Rad Laboratories, Inc.
  12.5.1 Company Overview
  12.5.2 Revenue Analysis
  12.5.3 Product Portfolio
  12.5.4 Recent Developments
12.6 Genlantis Inc.
  12.6.1 Company Overview
  12.6.2 Geographical Presence
  12.6.3 Product Portfolio
  12.6.4 Recent Developments
12.7 Lonza
  12.7.1 Company Overview
  12.7.2 Revenue Analysis
  12.7.3 Product Portfolio
  12.7.4 Recent Developments
12.8 Maxcyte Inc
  12.8.1 Company Overview
  12.8.2 Geographical Presence
  12.8.3 Product Portfolio
  12.8.4 Recent Developments
12.9 Mirus Bio Llc
  12.9.1 Company Overview
  12.9.2 Geographical Presence
  12.9.3 Product Portfolio
  12.9.4 Recent Developments
12.10 Polyplus Transfection
  12.10.1 Company Overview
  12.10.2 Geographical Presence
  12.10.3 Product Portfolio
  12.10.4 Recent Developments
12.11 Signagen Laboratories.
  12.11.1 Company Overview
  12.11.2 Geographical Presence
  12.11.3 Product Portfolio
  12.11.4 Recent Development

13 RELATED REPORTS

LIST OF FIGURES

Figure 1 Global Transfection Reagents And Equipment Market: Segmentation
Figure 2 Global Transfection Reagents And Equipment Market:
Data Triangulation
Figure 3 Global Transfection Reagents And Equipment Market:
Research Snapshot
Figure 4 Global Transfection Reagents And Equipment Market
Bottom Up Approach
Figure 5 Global Transfection Reagents And Equipment Market
Top Down Approach
Figure 6 Global Transfection Reagents And Equipment Market:
Interview Demographics
Figure 7 Global Transfection Reagents And Equipment Market:
Biochemical Methods
Figure 8 Global Transfection Reagents And Equipment Market: Physical Methods
Figure 9 Global Transfection Reagents And Equipment Market: Viral Methods
Figure 10 Drivers, Restraints, Opportunities And Challenges Of Global Transfection Reagents And Equipment Market
Figure 11 Global Transfection Reagents And Equipment Market: Segmentation
Figure 12 North America Is Anticipated To Dominate The Transfection Reagents And Equipment Market And Asia Pacific Is Estimated To Be Increasing With The Strong Cagr In The Forecast Period From 2018 To 2025
Figure 13 Rising Research Activities In Cell Science And Increase In Demand Of Chimeric Genes Are Expected To Drive The Market For Global Transfection Reagents And Equipment In The Forecast
Period 2018 To 2025
Figure 14 Reagents Is Expected To Account For The Largest Share Of The Global Transfection Reagents And Equipment Market In 2018 & 2025
Figure 15 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Transfection Reagents And Equipment Market In The Forecast Period From 2018 To 2025
Figure 16 Global Transfection Reagents And Equipment Market: By Product, 2017
Figure 17 Global Transfection Reagents And Equipment Market: By Method, 2017
Figure 18 Global Transfection Reagents And Equipment Market:
By Application, 2017
Figure 19 Global Transfection Reagents And Equipment Market: By End User, 2017
Figure 20 Global Transfection Reagents And Equipment Market Snapshot (2017)
Figure 21 Global Transfection Reagents And Equipment Market:
By Geography (2017)
Figure 22 Global Transfection Reagents And Equipment Market:
By Geography (2018)
Figure 23 Global Transfection Reagents And Equipment Market:
By Country (2017 & 2025)
Figure 24 Global Transfection Reagents And Equipment Market:
By Products (2018 - 2025)
Figure 25 North America Transfection Reagents And Equipment Market
Snapshot (2017)
Figure 26 North America Transfection Reagents And Equipment: By Country (2017)
Figure 27 North America Transfection Reagents And Equipment:
By Country (2018 & 2025)
Figure 28 North America Transfection Reagents And Equipment Market
By Country (2017 & 2025)
Figure 29 North America Transfection Reagents And Equipment Market, By Products (2018 To 2025)
Figure 30 Europe Transfection Reagents And Equipment Market Snapshot (2017)
Figure 31 Europe Transfection Reagents And Equipment: By Country (2017)
Figure 32 Europe Transfection Reagents And Equipment: By Country (2018 & 2025)
Figure 33 Europe Transfection Reagents And Equipment Market
By Country (2017 & 2025)
Figure 34 Europe Transfection Reagents And Equipment Market, By Products (2018 To 2025)
Figure 35 Asia-Pacific Transfection Reagents And Equipment Market
Snapshot (2017)
Figure 36 Asia-Pacific Transfection Reagents And Equipment: By Country (2017)
Figure 37 Asia-Pacific Transfection Reagents And Equipment:
By Country (2018 & 2025)
Figure 38 Asia-Pacific Transfection Reagents And Equipment Market
By Country (2017 & 2025)
Figure 39 Asia-Pacific Transfection Reagents And Equipment Market, By Products (2018 To 2025)
Figure 40 South America Transfection Reagents And Equipment Markets Napshot (2017)
Figure 41 South America Transfection Reagents And Equipment: By Country (2017)
Figure 42 South America Transfection Reagents And Equipment:
By Country (2018 & 2025)
Figure 43 South America Transfection Reagents And Equipment Market
By Country (2017 & 2025)
Figure 44 South America Transfection Reagents And Equipment Market, By Product (2018 To 2025)
Figure 45 Middle East And Africa Transfection Reagents And Equipment Marketsnapshot (2017)
Figure 46 Middle East And Africa Transfection Reagents And Equipment:
By Country (2017)
Figure 47 Middle East And Africa Transfection Reagents And Equipment:
By Country (2018 & 2025)
Figure 48 Middle East And Africa Transfection Reagents And Equipment Market
By Country (2017 & 2025)
Figure 49 Middle East And Africa Transfection Reagents And Equipment Market, By Products (2018 To 2025)
Figure 50 Global Transfection Reagents And Equipment Market:
Company Share 2017 (%)
Figure 51 North America Transfection Reagents And Equipment Market:
Company Share 2017 (%)
Figure 52 Europe Transfection Reagents And Equipment Market:
Company Share 2017 (%)
Figure 53 Asia-Pacific Transfection Reagents And Equipment Market:
Company Share 2017 (%)


More Publications